Integration of DCE-MRI and DW-MRI Quantitative Parameters for Breast Lesion Classification

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Fusco, Roberta ^a   Sansone, Mario ^b   Filice, Salvatore ^a   Granata, Vincenza ^a   Catalano, Orlando ^a   Amato, Daniela Maria ^a   Di Bonito, Maurizio ^a   D'Aiuto, Massimiliano ^a   Capasso, Immacolata ^a   Rinaldo, Massimo ^a   Petrillo, Antonella ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GADOTERATE MEGLUMINE; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ARTICLE; BREAST CARCINOMA; BREAST FIBROADENOMA; BREAST LESION; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; ADOLESCENT; ADULT; BREAST TUMOR; CLASSIFICATION; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MIDDLE AGED; RADIOGRAPHY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84939833192     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/237863     Document Type: Article

References (49)

1. W. Huang, P. R. Fisher, K. Dulaimy, L. A. Tudorica, B. O'Hea, and T. M. Button, "Detection of breast malignancy: diagnostic MR protocol for improved specificity," Radiology, vol. 232, no. 2, pp. 585-591, 2004.
2. S. H. Heywang-Köbrunner, P. Viehweg, A. Heinig, and C. Küchler, "Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions," European Journal of Radiology, vol. 24, no. 2, pp. 94-108, 1997.
3. M. D. Schnall, S. Rosten, S. Englander, S. G. Orel, and L. W. Nunes, "A combined architectural and kinetic interpretation model for breast MR images," Academic Radiology, vol. 8, no. 7, pp. 591-597, 2001.
4. K. Kinkel, T. H. Helbich, L. J. Esserman et al., "Dynamic highspatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability," American Journal of Roentgenology, vol. 175, no. 1, pp. 35-43, 2000.
5. R. M. L. Warren, L. Pointon, D. Thompson et al., "Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis," Radiology, vol. 236, no. 3, pp. 779-788, 2005.
6. N.H. G.M. Peters, I. H. M. Borel Rinkes, N. P. A. Zuithoff,W. P. T.M. Mali, K.G.M. Moons, and P.H.M. Peeters, "Meta-analysis ofMRimaging in the diagnosis of breast lesions," Radiology, vol. 246, no. 1, pp. 116-124, 2008.
7. L. W. Nunes, M. Schnall, E. S. Siegelman et al., "Diagnostic performance characteristics of architectural features revealed by high spatial-resolutionMR imaging of the breast," American Journal of Roentgenology, vol. 169, no. 2, pp. 409-415, 1997.
8. C. K. Kuhl, P. Mielcareck, S. Klaschik et al., "Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?" Radiology, vol. 211, no. 1, pp. 101-110, 1999.
9. M. C. Lloyd, P. Allam-Nandyala, C. N. Purohit et al., "Using image analysis as a tool for assessment of prognostic and predictive biomarkers for breast cancer: how reliable is it?" Journal of Pathology Informatics, vol. 1, article 29, 2010.
10. M.V. Knopp, F. L. Giesel,H. Marcos,H. vonTengg-Kobligk, and P. Choyke, "Dynamic contrast-enhanced magnetic resonance imaging in oncology," Topics in Magnetic Resonance Imaging, vol. 12, no. 4, pp. 301-308, 2001.
11. M. Y. Su, Y. C. Cheung, J. P. Fruehauf et al., "Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer," Journal of Magnetic Resonance Imaging, vol. 18, no. 4, pp. 467-477, 2003.
12. P. Gibbs, G. P. Liney, M. D. Pickles, B. Zelhof, G. Rodrigues, and L.W. Turnbull, "Correlation of ADCandT2measurements with cell density in prostate cancer at 3.0 Tesla," Investigative Radiology, vol. 44, no. 9, pp. 572-576, 2009.
13. Y. Matsumoto, M. Kuroda, R. Matsuya et al., "In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology," Oncology Reports, vol. 22, no. 3, pp. 641-648, 2009.
14. G. Brix, J. Griebel, F. Kiessling, and F. Wenz, "Tracer kinetic modelling of tumour angiogenesis based on dynamic contrastenhanced CT and MRI measurements," European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, supplement 1, pp. S30-S51, 2010.
15. S. Sourbron, "Technical aspects of MR perfusion," European Journal of Radiology, vol. 76, no. 3, pp. 304-313, 2010.
16. M. Sansone, R. Fusco, A. Petrillo, M. Petrillo, and M. Bracale, "An expectation-maximisation approach for simultaneous pixel classification and tracer kinetic modelling in dynamic contrast enhanced-magnetic resonance imaging," Medical and Biological Engineering and Computing, vol. 49, no. 4, pp. 485-495, 2011.
17. R. Fusco, M. Sansone, M. Petrillo, and A. Petrillo, "Influence of parameterization on tracer kinetic modeling in DCE-MRI," Journal of Medical and Biological Engineering, vol. 34, no. 2, pp. 157-163, 2014.
18. R. Fusco, M. Sansone, S. Maffei, N. Raiano, and A. Petrillo, "Dynamic contrast-enhanced MRI in breast cancer: a comparison between distributed and compartmental tracer kinetic models," Journal of Biomedical Graphics and Computing, vol. 2, no. 2, pp. 23-26, 2012.
19. M. Goto, H. Ito, K. Akazawa et al., "Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features," Journal of Magnetic Resonance Imaging, vol. 25, no. 1, pp. 104-112, 2007.
20. R. Fusco, S. Filice, V. Granata et al., "Can semi-quantitative evaluation of uncertain (type II) time-intensity curves improve diagnosis in breast DCE-MRI?" Journal of Biomedical Science and Engineering, vol. 6, no. 3, pp. 418-425, 2013.
21. D. J. Collins and A. R. Padhani, "Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges," IEEE Engineering in Medicine and Biology Magazine, vol. 23, no. 5, pp. 65-83, 2004.
22. P. S. Tofts, "Modeling tracer kinetics in dynamic Gd-DTPAMR imaging," Journal of Magnetic Resonance Imaging, vol. 7, no. 1, pp. 91-101, 1997.
23. C. Yang, G. S. Karczmar, M. Medved, and W. M. Stadler, "Estimating the arterial input function using two reference tissues in dynamic contrast-enhanced MRI studies: fundamental concepts and simulations,"Magnetic Resonance inMedicine, vol. 52, no. 5, pp. 1110-1117, 2004.
24. G. Brix, W. Semmler, R. Port, L. R. Schad, G. Layer, and W. J. Lorenz, "Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging," Journal of Computer Assisted Tomography, vol. 15, no. 4, pp. 621-628, 1991.
25. T. E. Yankeelov, J. J. Luci, M. Lepage et al., "Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model," Magnetic Resonance Imaging, vol. 23, no. 4, pp. 519-529, 2005.
26. R. Fusco, A. Petrillo, M. Petrillo, andM. Sansone, "Use of tracer kinetic models for selection of semi-quantitative features for DCE-MRI data classification," AppliedMagnetic Resonance, vol. 44, no. 11, pp. 1311-1324, 2013.
27. D. Le Bihan, E. Breton, and D. Lallemand, "MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders," Radiology, vol. 161, no. 2, pp. 401-407, 1986.
28. D. Le Bihan, E. Breton, D. Lallemand, M.-L. Aubin, J. Vignaud, andM. Laval-Jeantet, "Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging," Radiology, vol. 168, no. 2, pp. 497-505, 1988.
29. A. Luciani, A. Vignaud, M. Cavet et al., "Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study," Radiology, vol. 249, no. 3, pp. 891-899, 2008.
30. R. Wirestam, M. Borg, S. Brockstedt, A. Lindgren, S. Holtas, and F. Stahlberg, "Perfusion-related parameters in intravoxel incoherent motion MR imaging compared with CBV and CBF measured by dynamic susceptibility-contrast MR technique," Acta Radiologica, vol. 42, no. 2, pp. 123-128, 2001.
31. T. Moteki and H. Horikoshi, "Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted echo-planar MR with three values of gradient b-factor," Journal of Magnetic Resonance Imaging, vol. 24, no. 3, pp. 637-645, 2006.
32. V. Callot, E. Bennett, U. K. M. Decking, R. S. Balaban, and H. Wen, "In vivo study of microcirculation in canine myocardium using the IVIM method," Magnetic Resonance in Medicine, vol. 50, no. 3, pp. 531-540, 2003.
33. L. Yao andU. Sinha, "Imaging the microcirculatory proton fraction of muscle with diffusion-weighted echo-planar imaging," Academic Radiology, vol. 7, no. 1, pp. 27-32, 2000.
34. H. J. Weinmann, M. Laniado, andW.Mützel, "Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers," Physiological Chemistry and Physics and Medical NMR, vol. 16, no. 2, pp. 167-172, 1984.
35. M. C. Schabel, G. R. Morrell, K. Y. Oh, C. A. Walczak, R. B. Barlow, and L. A. Neumayer, "Pharmacokinetic mapping for lesion classification in dynamic breast MRI," Journal ofMagnetic Resonance Imaging, vol. 31, no. 6, pp. 1371-1378, 2010.
36. H. L. Sang, H. K. Jong, S. P. Jeong et al., "Texture analysis of lesion perfusion volumes in dynamic contrast-enhanced breast MRI," in Proceedings of the 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro (ISBI '08), pp. 1545-1548, Paris, France, May 2008.
37. T. Twellmann,A. Saalbach, M. O. Leach, and T.W. Nattkemper, "Image fusion for dynamic contrast enhanced magnetic resonance imaging," BioMedical Engineering Online, vol. 3, article 35, 2004.
38. S. H. Lee, J. H. Kim, N. Cho et al., "Multilevel analysis of spatiotemporal association features for differentiation of tumor enhancement patterns in breast DCE-MRI," Medical Physics, vol. 37, no. 8, pp. 3940-3956, 2010.
39. W. J. Krzanowski, Principles of Multivariate Analysis: A User's Perspective, Oxford University Press, New York, NY, USA, 1988.
40. T. Fawcett, "ROC graphs: notes and practical considerations for researchers," HP Labs Tech. Rep., HP Labs, Palo Alto, Calif, USA, 2003.
41. E. F. Schisterman, N. J. Perkins, A. Liu, and H. Bondell, "Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples," Epidemiology, vol. 16, no. 1, pp. 73-81, 2005.
42. H. Rahbar, S. C. Partridge, W. B. DeMartini et al., "In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters," Radiology, vol. 263, no. 2, pp. 374-382, 2012.
43. S. Kul, A. Cansu, E. Alhan, H. Dinc, G. Gunes, and A. Reis, "Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors," American Journal of Roentgenology, vol. 196, no. 1, pp. 210-217, 2011.
44. S. C. Partridge, W. B. DeMartini, B. F. Kurland, P. R. Eby, S. W. White, and C. D. Lehman, "Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value," American Journal of Roentgenology, vol. 193, no. 6, pp. 1716-1722, 2009.
45. A. Jena, S. Taneja, and S. B. Mehta, "Integrated quantitative DCE-MRI and DW-MRI to characterize breast lesions," European Journal of Radiology, vol. 81, pp. S64-S65, 2012.
46. L.-M. Wu, J.-N. Hu, H.-Y. Gu, J. Hua, J. Chen, and J.-R. Xu, "Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?" Breast Cancer Research and Treatment, vol. 135, no. 1, pp. 17-28, 2012.
47. N. C. Atuegwu, L. R. Arlinghaus, X. Li et al., "Parameterizing the logisticmodel of tumor growth by DW-MRI and DCE-MRI data to predict treatment response and changes in breast cancer cellularity during neoadjuvant chemotherapy," Translational Oncology, vol. 6, no. 3, pp. 256-264, 2013.
48. H. Cai, L. Liu, Y. Peng, Y. Wu, and L. Li, "Diagnostic assessment by dynamic contrast-enhanced and diffusion-weighted magnetic resonance in differentiation of breast lesions under different imaging protocols," BMC Cancer, vol. 14, no. 1, article 366, 2014.
49. H. Cai, Y. Peng, C. Ou, M. Chen, and L. Li, "Diagnosis of breast masses from dynamic contrast-enhanced and diffusionweighted MR: a machine learning approach," PLoS ONE, vol. 9, no. 1, Article ID e87387, 2014.